ANI Pharmaceuticals Inc (NAS:ANIP)
$ 68.05 2.17 (3.29%) Market Cap: 1.43 Bil Enterprise Value: 1.52 Bil PE Ratio: 82.99 PB Ratio: 3.22 GF Score: 81/100

Q1 2023 ANI Pharmaceuticals Inc Earnings Call Transcript

May 08, 2023 / 12:30PM GMT
Release Date Price: $42.58 (+8.79%)
Operator

Good day, everyone, and welcome to today's ANI Pharmaceuticals' Q1 2023 Earnings Call. (Operator Instructions) Please note this call will be recorded. (Operator Instructions)

It is now my pleasure to turn today's call over to Judy DiClemente. Please go ahead.

Judy DiClemente

Thank you, Ashley. Welcome to ANI Pharmaceuticals' Q1 2023 Earnings Results Call. This is Judy DiClemente of Insight Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at www.anipharmaceuticals.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events and the company's future performance may be considered forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot